Groupe la Francaise’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.53M Buy
21,527
+3,013
+16% +$646K 0.05% 215
2026
Q1
$4.09M Buy
18,514
+1,589
+9% +$389K 0.06% 213
2025
Q4
$4.29M Buy
16,925
+511
+3% +$128K 0.06% 191
2025
Q3
$4.06M Sell
16,414
-113
-0.7% -$27K 0.05% 188
2025
Q2
$3.95M Buy
16,527
+2,693
+19% +$627K 0.06% 168
2025
Q1
$3.1M Buy
13,834
+1,850
+15% +$407K 0.07% 188
2024
Q4
$2.48M Buy
+11,984
New +$2.63M 0.06% 171

Other funds holding STE

Groupe la Francaise's STE Position: Q2 2026 in Review

Groupe la Francaise increased its Steris (STE) stake by 16% in Q2 2026, buying an estimated $646K and bringing the position to 21,527 shares worth $4.53M. The position accounts for 0.05% of the portfolio, ranked #215.

Groupe la Francaise first reported a position in STE in Q4 2024 and has held it in 7 quarters since. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Groupe la Francaise held 21,527 shares of Steris worth $4.53M as of Q2 2026.
  • Groupe la Francaise bought 3,013 Steris shares in Q2 2026, an estimated $646K.
  • Steris made up 0.05% of Groupe la Francaise's portfolio in Q2 2026, its #215 holding.
  • Groupe la Francaise first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.